{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:11:42Z","timestamp":1795018302186,"version":"4.10.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00996-y","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:10:58Z","timestamp":1760094658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the efficacy of intranasal oxytocin (OXT) for anxiety and stress-related disorders through functional magnetic resonance imaging (fMRI) study: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Reza","family":"Moshfeghinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Sanaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Kavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad","family":"Barzegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mahmoud","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Arab Bafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrina","family":"Habibzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Boroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Shalbafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"1","key":"996_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s43045-023-00315-3","volume":"30","author":"SF Javaid","year":"2023","unstructured":"Javaid SF, Hashim IJ, Hashim MJ, Stip E, Samad MA, Ahbabi AA. Epidemiology of anxiety disorders: global burden and sociodemographic associations. Middle East Curr Psychiatry. 2023;30(1):44.","journal-title":"Middle East Curr Psychiatry"},{"issue":"1","key":"996_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s43045-023-00340-2","volume":"30","author":"MSSM Vadakkiniath","year":"2023","unstructured":"Vadakkiniath MSSM. Prevalence and correlates of stress, anxiety, and depression in patients with chronic diseases: a cross-sectional study. Middle East Curr Psychiatry. 2023;30(1):66.","journal-title":"Middle East Curr Psychiatry"},{"issue":"8","key":"996_CR3","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.chiabu.2014.01.017","volume":"38","author":"P Spinhoven","year":"2014","unstructured":"Spinhoven P, Penninx BW, van Hemert AM, de Rooij M, Elzinga BM. Comorbidity of PTSD in anxiety and depressive disorders: prevalence and shared risk factors. Child Abuse Negl. 2014;38(8):1320\u201330.","journal-title":"Child Abuse Negl"},{"key":"996_CR4","unstructured":"Chu BMK, Sanvictores T, Physiology et al. Stress reaction 2024 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541120\/"},{"key":"996_CR5","doi-asserted-by":"publisher","first-page":"104136","DOI":"10.1016\/j.ijnurstu.2021.104136","volume":"126","author":"N Yunitri","year":"2022","unstructured":"Yunitri N, Chu H, Kang XL, Jen HJ, Pien LC, Tsai HT, et al. Global prevalence and associated risk factors of posttraumatic stress disorder during COVID-19 pandemic: A meta-analysis. Int J Nurs Stud. 2022;126:104136.","journal-title":"Int J Nurs Stud"},{"issue":"10277","key":"996_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","volume":"397","author":"BWJH Penninx","year":"2021","unstructured":"Penninx BWJH, Pine DS, Holmes EA, Reif A. Anxiety disorders. Lancet. 2021;397(10277):914\u201327.","journal-title":"Lancet"},{"issue":"24","key":"996_CR7","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1001\/jama.2022.22744","volume":"328","author":"KL Szuhany","year":"2022","unstructured":"Szuhany KL, Simon NM. Anxiety disorders: a review. JAMA. 2022;328(24):2431\u201345.","journal-title":"JAMA"},{"key":"996_CR8","doi-asserted-by":"publisher","first-page":"110450","DOI":"10.1016\/j.pnpbp.2021.110450","volume":"113","author":"L Mei","year":"2022","unstructured":"Mei L, Gao Y, Chen M, Zhang X, Yue W, Zhang D, et al. Overlapping common genetic architecture between major depressive disorders and anxiety and stress-related disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022;113:110450.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"996_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1176\/appi.ajp.2020.20121738","volume":"178","author":"NH Kalin","year":"2021","unstructured":"Kalin NH, Trauma. Resilience, anxiety disorders, and PTSD. Am J Psychiatry. 2021;178(2):103\u20135.","journal-title":"Am J Psychiatry"},{"issue":"3\u20134","key":"996_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/bdr2.1971","volume":"114","author":"RM Simeone","year":"2022","unstructured":"Simeone RM, Downing KF, Bobo WV, Grosse SD, Khanna AD, Farr SL. Post-traumatic stress disorder, anxiety, and depression among adults with congenital heart defects. Birth Defects Res. 2022;114(3\u20134):124\u201335.","journal-title":"Birth Defects Res"},{"issue":"3","key":"996_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/wps.20919","volume":"20","author":"DJ Stein","year":"2021","unstructured":"Stein DJ, Craske MG, Rothbaum BO, Chamberlain SR, Fineberg NA, Choi KW, et al. The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management. World Psychiatry. 2021;20(3):336\u201356.","journal-title":"World Psychiatry"},{"key":"996_CR12","doi-asserted-by":"publisher","first-page":"100191","DOI":"10.1016\/j.ynstr.2019.100191","volume":"11","author":"N Daviu","year":"2019","unstructured":"Daviu N, Bruchas MR, Moghaddam B, Sandi C, Beyeler A. Neurobiological links between stress and anxiety. Neurobiol Stress. 2019;11:100191.","journal-title":"Neurobiol Stress"},{"issue":"12","key":"996_CR13","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.biopsych.2010.04.027","volume":"67","author":"KJ Ressler","year":"2010","unstructured":"Ressler KJ. Amygdala activity, fear, and anxiety: modulation by stress. Biol Psychiatry. 2010;67(12):1117\u20139.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"996_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41386-021-01155-7","volume":"47","author":"M Alexandra Kredlow","year":"2022","unstructured":"Alexandra Kredlow M, Fenster RJ, Laurent ES, Ressler KJ, Phelps EA. Prefrontal cortex, amygdala, and threat processing: implications for PTSD. Neuropsychopharmacology. 2022;47(1):247\u201359.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"996_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/neurolint13030038","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, et al. Selective serotonin reuptake inhibitors and adverse effects: A narrative review. Neurol Int. 2021;13(3):387\u2013401.","journal-title":"Neurol Int"},{"issue":"6","key":"996_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0269881119845799","volume":"33","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Hayes J, Goodwin GM, Baldwin DS, Cowen PJ, Nutt DJ. Antidepressants, withdrawal, and addiction; where are we now? J Psychopharmacol. 2019;33(6):655\u20139.","journal-title":"J Psychopharmacol"},{"key":"996_CR17","doi-asserted-by":"crossref","unstructured":"Takayanagi Y, Onaka T. Roles of Oxytocin in stress responses, allostasis and resilience. Int J Mol Sci. 2021;23(1).","DOI":"10.3390\/ijms23010150"},{"key":"996_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-981-32-9705-0_7","volume":"1191","author":"S Yoon","year":"2020","unstructured":"Yoon S, Kim YK. The role of the Oxytocin system in anxiety disorders. Adv Exp Med Biol. 2020;1191:103\u201320.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"996_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1037\/bne0000074","volume":"129","author":"R Sobota","year":"2015","unstructured":"Sobota R, Mihara T, Forrest A, Featherstone RE, Siegel SJ. Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism. Behav Neurosci. 2015;129(4):389\u201398.","journal-title":"Behav Neurosci"},{"issue":"11","key":"996_CR20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.neuron.2023.03.014","volume":"111","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li A, Bair-Marshall C, Xu H, Jee HJ, Zhu E, et al. Oxytocin promotes prefrontal population activity via the PVN-PFC pathway to regulate pain. Neuron. 2023;111(11):1795\u2013e8117.","journal-title":"Neuron"},{"issue":"1","key":"996_CR21","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1038\/s41467-017-02173-0","volume":"8","author":"T Raam","year":"2017","unstructured":"Raam T, McAvoy KM, Besnard A, Veenema AH, Sahay A. Hippocampal Oxytocin receptors are necessary for discrimination of social stimuli. Nat Commun. 2017;8(1):2001.","journal-title":"Nat Commun"},{"issue":"9","key":"996_CR22","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.psyneuen.2013.06.019","volume":"38","author":"M Olff","year":"2013","unstructured":"Olff M, Frijling JL, Kubzansky LD, Bradley B, Ellenbogen MA, Cardoso C, et al. The role of Oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences. Psychoneuroendocrinology. 2013;38(9):1883\u201394.","journal-title":"Psychoneuroendocrinology"},{"key":"996_CR23","doi-asserted-by":"crossref","unstructured":"Houlton S, Vaidya JG, Breheny P, Strathearn L. Intranasal Oxytocin increases head motion during functional MRI scanning. Res Sq. 2024.","DOI":"10.21203\/rs.3.rs-3912105\/v1"},{"key":"996_CR24","doi-asserted-by":"crossref","unstructured":"Triana-Del Rio R, Ranade S, Guardado J, LeDoux J, Klann E, Shrestha P. The modulation of emotional and social behaviors by Oxytocin signaling in limbic network. Front Mol Neurosci. 2022;15.","DOI":"10.3389\/fnmol.2022.1002846"},{"key":"996_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.psyneuen.2013.11.018","volume":"40","author":"SB Koch","year":"2014","unstructured":"Koch SB, van Zuiden M, Nawijn L, Frijling JL, Veltman DJ, Olff M. Intranasal Oxytocin as strategy for medication-enhanced psychotherapy of PTSD: salience processing and fear Inhibition processes. Psychoneuroendocrinology. 2014;40:242\u201356.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"996_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Reviews. 2021;10(1):1\u201311.","journal-title":"Syst Reviews"},{"key":"996_CR27","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association. 2013."},{"key":"996_CR28","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. 2008.","DOI":"10.1002\/9780470712184"},{"key":"996_CR29","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"5","key":"996_CR30","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/npp.2015.278","volume":"41","author":"JL Frijling","year":"2016","unstructured":"Frijling JL, van Zuiden M, Koch SB, Nawijn L, Veltman DJ, Olff M. Intranasal oxytocin affects amygdala functional connectivity after trauma script-driven imagery in distressed recently trauma-Exposed individuals. Neuropsychopharmacology. 2016;41(5):1286\u201396.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"996_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/scan\/nsv116","volume":"11","author":"JL Frijling","year":"2016","unstructured":"Frijling JL, van Zuiden M, Koch SB, Nawijn L, Veltman DJ, Olff M. Effects of intranasal oxytocin on amygdala reactivity to emotional faces in recently trauma-exposed individuals. Soc Cogn Affect Neurosci. 2016;11(2):327\u201336.","journal-title":"Soc Cogn Affect Neurosci"},{"issue":"8","key":"996_CR32","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/npp.2016.1","volume":"41","author":"SB Koch","year":"2016","unstructured":"Koch SB, van Zuiden M, Nawijn L, Frijling JL, Veltman DJ, Olff M. Intranasal Oxytocin normalizes amygdala functional connectivity in posttraumatic stress disorder. Neuropsychopharmacology. 2016;41(8):2041\u201351.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"996_CR33","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/npp.2015.299","volume":"41","author":"SB Koch","year":"2016","unstructured":"Koch SB, van Zuiden M, Nawijn L, Frijling JL, Veltman DJ, Olff M. Intranasal Oxytocin administration dampens amygdala reactivity towards emotional faces in male and female PTSD patients. Neuropsychopharmacology. 2016;41(6):1495\u2013504.","journal-title":"Neuropsychopharmacology"},{"key":"996_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.psyneuen.2016.01.020","volume":"66","author":"L Nawijn","year":"2016","unstructured":"Nawijn L, van Zuiden M, Koch SB, Frijling JL, Veltman DJ, Olff M. Intranasal Oxytocin enhances neural processing of monetary reward and loss in post-traumatic stress disorder and traumatized controls. Psychoneuroendocrinology. 2016;66:228\u201337.","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"996_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/scan\/nsw123","volume":"12","author":"L Nawijn","year":"2017","unstructured":"Nawijn L, van Zuiden M, Koch SB, Frijling JL, Veltman DJ, Olff M. Intranasal Oxytocin increases neural responses to social reward in post-traumatic stress disorder. Soc Cogn Affect Neurosci. 2017;12(2):212\u201323.","journal-title":"Soc Cogn Affect Neurosci"},{"issue":"2","key":"996_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.euroneuro.2018.12.002","volume":"29","author":"SBJ Koch","year":"2019","unstructured":"Koch SBJ, van Zuiden M, Nawijn L, Frijling JL, Veltman DJ, Olff M. Effects of intranasal Oxytocin on distraction as emotion regulation strategy in patients with post-traumatic stress disorder. Eur Neuropsychopharmacol. 2019;29(2):266\u201377.","journal-title":"Eur Neuropsychopharmacol"},{"key":"996_CR37","doi-asserted-by":"publisher","first-page":"111368","DOI":"10.1016\/j.pscychresns.2021.111368","volume":"317","author":"LM Sippel","year":"2021","unstructured":"Sippel LM, Flanagan JC, Holtzheimer PE, Moran-Santa-Maria MM, Brady KT, Joseph JE. Effects of intranasal Oxytocin on threat- and reward-related functional connectivity in men and women with and without childhood abuse-related PTSD. Psychiatry Res Neuroimaging. 2021;317:111368.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"996_CR38","doi-asserted-by":"publisher","first-page":"111345","DOI":"10.1016\/j.pscychresns.2021.111345","volume":"316","author":"KI Crum","year":"2021","unstructured":"Crum KI, Flanagan JC, Vaughan B, Aloi J, Moran-Santa Maria MM, Back SE, et al. Oxytocin, PTSD, and sexual abuse are associated with attention network intrinsic functional connectivity. Psychiatry Res Neuroimaging. 2021;316:111345.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"4","key":"996_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1037\/pha0000197","volume":"26","author":"JC Flanagan","year":"2018","unstructured":"Flanagan JC, Hand A, Jarnecke AM, Moran-Santa Maria MM, Brady KT, Joseph JE. Effects of Oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder. Exp Clin Psychopharmacol. 2018;26(4):391\u2013402.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"996_CR40","doi-asserted-by":"publisher","first-page":"1606626","DOI":"10.1080\/20008198.2019.1606626","volume":"10","author":"JC Flanagan","year":"2019","unstructured":"Flanagan JC, Sippel LM, Santa Maria MMM, Hartwell KJ, Brady KT, Joseph JE. Impact of Oxytocin on the neural correlates of fearful face processing in PTSD related to childhood trauma. Eur J Psychotraumatol. 2019;10(1):1606626.","journal-title":"Eur J Psychotraumatol"},{"issue":"9","key":"996_CR41","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1038\/npp.2014.53","volume":"39","author":"S Dodhia","year":"2014","unstructured":"Dodhia S, Hosanagar A, Fitzgerald DA, Labuschagne I, Wood AG, Nathan PJ, et al. Modulation of resting-state amygdala-frontal functional connectivity by Oxytocin in generalized social anxiety disorder. Neuropsychopharmacology. 2014;39(9):2061\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"996_CR42","doi-asserted-by":"publisher","first-page":"109930","DOI":"10.1016\/j.neuropharm.2024.109930","volume":"251","author":"A Flechsenhar","year":"2024","unstructured":"Flechsenhar A, Levine SM, M\u00fcller LE, Herpertz SC, Bertsch K. Oxytocin and social learning in socially anxious men and women. Neuropharmacology. 2024;251:109930.","journal-title":"Neuropharmacology"},{"issue":"2","key":"996_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/npp.2014.168","volume":"40","author":"SM Gorka","year":"2015","unstructured":"Gorka SM, Fitzgerald DA, Labuschagne I, Hosanagar A, Wood AG, Nathan PJ, et al. Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder. Neuropsychopharmacology. 2015;40(2):278\u201386.","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"996_CR44","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/npp.2010.123","volume":"35","author":"I Labuschagne","year":"2010","unstructured":"Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, et al. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology. 2010;35(12):2403\u201313.","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"996_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1017\/S1461145711001489","volume":"15","author":"I Labuschagne","year":"2012","unstructured":"Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, et al. Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by Oxytocin. Int J Neuropsychopharmacol. 2012;15(7):883\u201396.","journal-title":"Int J Neuropsychopharmacol"},{"key":"996_CR46","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.cpnec.2022.100165","volume":"13","author":"D Marazziti","year":"2023","unstructured":"Marazziti D, Carter CS, Carmassi C, Della Vecchia A, Mucci F, Pagni G, et al. Sex matters: the impact of Oxytocin on healthy conditions and psychiatric disorders. Compr Psychoneuroendocrinology. 2023;13:100165.","journal-title":"Compr Psychoneuroendocrinology"},{"issue":"3","key":"996_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.psyneuen.2012.07.013","volume":"38","author":"C Cardoso","year":"2013","unstructured":"Cardoso C, Ellenbogen MA, Orlando MA, Bacon SL, Joober R. Intranasal Oxytocin attenuates the cortisol response to physical stress: a dose\u2013response study. Psychoneuroendocrinology. 2013;38(3):399\u2013407.","journal-title":"Psychoneuroendocrinology"},{"issue":"5719","key":"996_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.1105636","volume":"308","author":"D Huber","year":"2005","unstructured":"Huber D, Veinante P, Stoop R. Vasopressin and Oxytocin excite distinct neuronal populations in the central amygdala. Science. 2005;308(5719):245\u20138.","journal-title":"Science"},{"issue":"10","key":"996_CR49","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/jne.12300","volume":"27","author":"JL Frijling","year":"2015","unstructured":"Frijling JL, van Zuiden M, Nawijn L, Koch SB, Neumann ID, Veltman DJ, et al. Salivary Oxytocin and vasopressin levels in Police officers with and without post-traumatic stress disorder. J Neuroendocrinol. 2015;27(10):743\u201351.","journal-title":"J Neuroendocrinol"},{"key":"996_CR50","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s11682-014-9333-9","volume":"9","author":"C Feng","year":"2015","unstructured":"Feng C, Hackett PD, DeMarco AC, Chen X, Stair S, Haroon E, et al. Oxytocin and vasopressin effects on the neural response to social Cooperation are modulated by sex in humans. Brain Imaging Behav. 2015;9:754\u201364.","journal-title":"Brain Imaging Behav"},{"key":"996_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.psyneuen.2013.09.022","volume":"39","author":"JK Rilling","year":"2014","unstructured":"Rilling JK, DeMarco AC, Hackett PD, Chen X, Gautam P, Stair S, et al. Sex differences in the neural and behavioral response to intranasal Oxytocin and vasopressin during human social interaction. Psychoneuroendocrinology. 2014;39:237\u201348.","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"996_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/npp.2013.197","volume":"39","author":"VM Brown","year":"2014","unstructured":"Brown VM, LaBar KS, Haswell CC, Gold AL, McCarthy G, Morey RA. Altered resting-state functional connectivity of basolateral and centromedial amygdala complexes in posttraumatic stress disorder. Neuropsychopharmacology. 2014;39(2):351\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"996_CR53","doi-asserted-by":"publisher","first-page":"100236","DOI":"10.1016\/j.cpnec.2024.100236","volume":"19","author":"AJ Horn","year":"2024","unstructured":"Horn AJ, Cole S, Nazarloo HP, Nazarloo P, Davis JM, Carrier D, et al. Severe PTSD is marked by reduced Oxytocin and elevated vasopressin. Compr Psychoneuroendocrinology. 2024;19:100236.","journal-title":"Compr Psychoneuroendocrinology"},{"key":"996_CR54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpsychires.2017.12.014","volume":"98","author":"JC Flanagan","year":"2018","unstructured":"Flanagan JC, Sippel LM, Wahlquist A, Moran-Santa Maria MM, Back SE. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018;98:64\u20139.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"996_CR55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1017\/S109285290000047X","volume":"15","author":"M Olff","year":"2010","unstructured":"Olff M, Langeland W, Witteveen A, Denys D. A Psychobiological rationale for Oxytocin in the treatment of posttraumatic stress disorder. CNS Spectr. 2010;15(8):522\u201330.","journal-title":"CNS Spectr"},{"issue":"6","key":"996_CR56","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1521-0391.2013.12013.x","volume":"22","author":"N Clarke","year":"2013","unstructured":"Clarke N, Mun EY, Kelly S, White HR, Lynch K. Treatment outcomes of a combined cognitive behavior therapy and pharmacotherapy for a sample of women with and without substance abuse histories on an acute psychiatric unit: do therapeutic alliance and motivation matter? Am J Addictions. 2013;22(6):566\u201373.","journal-title":"Am J Addictions"},{"issue":"3","key":"996_CR57","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/070674371005500311","volume":"55","author":"S Thrasher","year":"2010","unstructured":"Thrasher S, Power M, Morant N, Marks I, Dalgleish T. Social support moderates outcome in a randomized controlled trial of exposure therapy and (or) cognitive restructuring for chronic posttraumatic stress disorder. Can J Psychiatry. 2010;55(3):187\u201390.","journal-title":"Can J Psychiatry"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00996-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:05:39Z","timestamp":1760097939000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00996-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00996-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because of the type of article (Review), there was no need for obtaining ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}